Calamos Advisors’s Tevogen Inc. Warrant TVGNW Stock Holding History

Calamos Advisors’s Portfolio TVGNW Stock Details TVGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$56.9K	Hold	1,000,000	–	–	﹤0.01%	941
2026 Q1	$33.9K	Hold	1,000,000	–	–	﹤0.01%	1157
2025 Q4	$42.2K	Hold	1,000,000	–	–	﹤0.01%	879
2025 Q3	$55K	Hold	1,000,000	–	–	﹤0.01%	866
2025 Q2	$69.9K	Hold	1,000,000	–	–	﹤0.01%	856
2025 Q1	$53.8K	Hold	1,000,000	–	–	﹤0.01%	840
2024 Q4	$54K	Hold	1,000,000	–	–	﹤0.01%	837
2024 Q3	$12.9K	Hold	1,000,000	–	–	﹤0.01%	868
2024 Q2	$20.1K	Hold	1,000,000	–	–	﹤0.01%	859
2024 Q1	$70K	Hold	1,000,000	–	–	﹤0.01%	812
2023 Q4	$40K	Hold	1,000,000	–	–	﹤0.01%	784
2023 Q3	$65.7K	Hold	1,000,000	–	–	﹤0.01%	772
2023 Q2	$41.2K	Hold	1,000,000	–	–	﹤0.01%	822
2023 Q1	$50.3K	Hold	1,000,000	–	–	﹤0.01%	928
2022 Q4	$7.5K	Buy	+1,000,000	New	+$29.1K	﹤0.01%	1121

Other funds holding TVGNW

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

DCM

Dupont Capital Management Wilmington, Delaware $2.18M AUM 50.81% 1-Year Est. Return

Calamos Advisors's TVGNW Position: Q2 2026 in Review

Calamos Advisors held its Tevogen Inc. Warrant (TVGNW) position steady in Q2 2026 at 1,000,000 shares worth $56.9K. The position accounts for ﹤0.01% of the portfolio, ranked #941.

Calamos Advisors first reported a position in TVGNW in Q4 2022 and has held it in 15 quarters since. The position peaked at $70K in Q1 2024. 3 funds tracked by Wall St. Rank hold TVGNW as of Q2 2026.

Calamos Advisors held 1,000,000 shares of Tevogen Inc. Warrant worth $56.9K as of Q2 2026.
Calamos Advisors left its Tevogen Inc. Warrant share count unchanged in Q2 2026.
Tevogen Inc. Warrant made up ﹤0.01% of Calamos Advisors's portfolio in Q2 2026, its #941 holding.
Calamos Advisors first reported a position in Tevogen Inc. Warrant in Q4 2022 and has held it in 15 quarters since.
Calamos Advisors's Tevogen Inc. Warrant position peaked at $70K in Q1 2024.
3 funds tracked by Wall St. Rank held Tevogen Inc. Warrant as of Q2 2026.

Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.